ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Chronic myeloid leukemia (CML) is a stem cell clonal disease characterized by the acquisition of a fusion protein, BCR-ABL1 oncogene, which leads to uncontrolled proliferation of myeloid elements in all stages of differentiation [1,2].